+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolotherapy Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Embolotherapy Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Embolotherapy Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829978
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Embolotherapy Market grew from USD 4.79 billion in 2024 to USD 5.22 billion in 2025. It is expected to continue growing at a CAGR of 8.94%, reaching USD 8.01 billion by 2030.

Revolutionizing Patient Outcomes Through Embolotherapy

Embolotherapy is rapidly redefining interventional radiology by offering minimally invasive solutions for treating vascular malformations, tumors, and fibroids. Its evolution from rudimentary particle embolization techniques to sophisticated liquid agents and vascular plugs underscores a commitment to enhancing patient outcomes while reducing procedural complexity. As healthcare providers seek alternatives to open surgery that minimize recovery times and hospital stays, embolotherapy has emerged as a cornerstone of modern therapeutic strategies.

This executive summary distills key developments shaping the embolotherapy landscape, from groundbreaking technological advances to geopolitical factors altering cost structures. By examining shifts in device innovation, the ripple effects of United States tariffs, granular segmentation insights, and regional dynamics, this analysis equips industry leaders with a holistic perspective. Strategic imperatives and actionable recommendations are designed to guide decision-makers in capitalizing on growth opportunities while navigating emerging challenges. The subsequent sections will offer a rigorous assessment grounded in robust methodology, ensuring that insights are both authoritative and applicable across diverse stakeholder groups.

Emerging Forces Reshaping the Embolotherapy Market Landscape

The embolotherapy market is undergoing transformative shifts driven by convergence of technology, clinical practice, and economic imperatives. Advances in polymer chemistry have yielded next-generation liquid embolics that offer superior control and occlusion durability, while calibrated microspheres now enable clinicians to precisely target tumor vasculature with minimal off-target effects. Vascular plugs equipped with radiopaque markers are streamlining deployment, reducing procedure times and radiation exposure.

Simultaneously, the adoption of image-guided navigation systems and artificial intelligence-powered platforms is redefining procedural planning and real-time decision making. These digital innovations are enhancing operator confidence and expanding the scope of treatable conditions. Health systems are increasingly shifting procedures to outpatient settings, unlocking cost efficiencies and elevating patient satisfaction. Coupled with regulatory approvals across major markets, these developments are catalyzing a broader acceptance of embolotherapy as a front-line intervention. As value-based care frameworks gain traction, providers are prioritizing technologies that demonstrably reduce complications and readmissions, thus reinforcing the momentum behind minimally invasive therapies.

Assessing 2025 US Tariffs and Their Ripple Effects

The introduction of new United States tariffs in 2025 has recalibrated supply chains and pricing dynamics across the embolotherapy ecosystem. Imported devices and raw materials, including polymer precursors for liquid embolics and specialized alloys for coils and plugs, have experienced cost escalations. In response, manufacturers are reevaluating sourcing strategies, with several accelerating investments in domestic production facilities to mitigate duty exposure and ensure uninterrupted supply.

These fiscal measures have prompted payers and providers to scrutinize total procedural costs, spurring negotiations on device pricing and bundling arrangements. Some clinical centers have initiated pilot programs to compare alternative embolic platforms and assess real-world efficacy relative to cost. The tariff environment has also stimulated industry consolidation as smaller suppliers explore strategic partnerships to diversify their offerings and share distribution networks. While short-term headwinds may exert pressure on margins, these adjustments are likely to foster greater resilience and innovation in the long term, positioning agile manufacturers to benefit from streamlined operations and enhanced local capabilities.

Nuanced Perspectives from Product, Application, and End User Segmentation

The embolotherapy market exhibits distinct dynamics across product, application, and end user segments. Within product type, balloons remain integral for temporary occlusion in high‐flow vascular networks, while coils-available in bare and fibered variants-continue to anchor aneurysm and malformation management. Liquid embolics such as ethylene vinyl alcohol copolymer and N-butyl cyanoacrylate are gaining traction for tumor devascularization and arteriovenous malformations, offering precise delivery and durable occlusion. Particle embolics, including calibrated microspheres and polyvinyl alcohol particles, deliver predictable flow control in uterine fibroid and peripheral embolization procedures. Plugs, ranging from vascular devices for peripheral occlusion to vena cava plugs for thromboembolic prophylaxis, are rapidly being adopted for their ease of use and radiopacity.

Application segmentation underscores neurovascular embolization as a leading driver, with subtypes targeting arteriovenous malformations, cerebral aneurysms, and tumor embolization. Peripheral embolization spans arterial and venous interventions, while prostate artery and uterine fibroid embolizations reflect growing demand for non‐surgical genitourinary therapies. Transarterial chemoembolization and radioembolization are consolidating their roles in oncology protocols, leveraging localized drug or isotope delivery to enhance tumor response. In end user markets, hospitals maintain majority share due to infrastructure and specialist availability. Ambulatory surgical centers are expanding service lines to include embolotherapy, and specialty clinics-comprising oncology and vascular centers-are differentiating through focused expertise and streamlined patient pathways.

These segmentation insights reveal that product innovation must align with evolving clinical applications and care settings. Manufacturers developing multi‐modal portfolios are poised to capture the widest patient population, especially when they offer integrated solutions tailored to specialized facilities.

Geographic Variations Driving Market Dynamics

Regional dynamics play a pivotal role in defining market trajectories. In the Americas, strong reimbursement frameworks and established interventional radiology networks drive sustained adoption of advanced embolic technologies. Leading clinical centers are at the forefront of trialing next‐generation platforms, reinforcing the region’s dominance in high-complexity procedures.

Within Europe, Middle East & Africa, regulatory harmonization under CE marking and expanding private healthcare facilities are enabling steady growth. Key markets in Western Europe continue to invest in digital and value-based care initiatives, while emerging economies in the Gulf and North Africa are allocating budgets toward interventional suites and specialist training.

The Asia-Pacific region exemplifies the fastest growth potential, fueled by rising healthcare expenditure, increasing incidence of oncology and fibroid cases, and government-led infrastructure programs. Markets in China, India, and Southeast Asia are witnessing rapid expansion of outpatient interventional services. Adoption is further accelerated by local partnerships and technology transfers that lower entry barriers for innovative embolic agents. Understanding these geographic variations is essential for stakeholders aiming to tailor market entry and expansion strategies that resonate with regional needs and regulatory landscapes.

Competitive Landscape and Strategic Positioning of Leading Firms

The competitive landscape blends global corporations and nimble specialists, each vying for leadership. Established device manufacturers leverage deep R&D pipelines to enhance material science and delivery systems, focusing on differentiated features such as bioresorbable polymers and integrated imaging. Market incumbents also pursue mergers and acquisitions to broaden their portfolios, address gaps in liquid or particle embolics, and achieve economies of scale in distribution.

Mid-tier players are carving out niches by prioritizing cost-effective offerings designed for emerging markets, capitalizing on localized manufacturing to undercut higher-priced imports. Simultaneously, start-ups are disrupting norms with novel drug-eluting embolic agents and smart microdevices that promise real-time feedback on occlusion quality. Partnerships with academic centers and consortia drive early clinical data generation, offering a pathway to accelerated adoption.

Competitive positioning increasingly hinges on comprehensive service models that include training programs, procedural support, and digital platforms for data analytics. Companies that succeed will blend technical innovation with robust stakeholder engagement, ensuring that product launches are supported by compelling clinical evidence and seamless integration into existing care pathways.

Strategic Imperatives for Industry Stakeholders

Industry leaders must adopt a multi-faceted approach to thrive in a rapidly evolving market. First, diversifying the supply chain by establishing regional manufacturing hubs will mitigate tariff exposure and enhance responsiveness to local regulatory changes. Concurrently, investing in next-generation embolic materials that combine biodegradability with therapeutic payloads can deliver differentiated value and strengthen competitive moats.

Collaborations with technology partners specializing in imaging, artificial intelligence, and digital health platforms will unlock new procedural efficiencies and data-driven insights. These alliances should extend beyond product development to include shared clinical studies that validate performance in real-world settings. Additionally, tailoring pricing strategies to reflect regional cost structures and payer expectations will be critical, especially in price-sensitive markets.

Training and education initiatives targeting emerging interventionalists in outpatient and specialty clinic environments will expand the overall addressable market. Offering modular support services-from case planning to remote proctoring-will enhance customer loyalty and facilitate early adoption of innovative devices. By executing these strategic imperatives, companies can navigate uncertainties, capitalize on growth pockets, and redefine standards of care in embolotherapy.

Methodological Rigor Behind the Market Analysis

This analysis is founded on a rigorous research framework that integrates primary and secondary data sources. Primary research involved structured interviews with key opinion leaders, interventional radiologists, and procurement managers, capturing firsthand perspectives on clinical needs, device preferences, and market barriers. Secondary research encompassed review of regulatory filings, peer-reviewed journals, company publications, and reputable industry databases to corroborate quantitative and qualitative findings.

Data triangulation ensured consistency across diverse inputs, with cross-validation performed through iterative expert reviews. A structured segmentation model was applied to organize insights by product type, application, and end user, facilitating comparative analysis and unveiling growth pockets. Regional market dynamics were assessed by synthesizing national healthcare statistics, reimbursement policies, and trade data, enabling a comprehensive view of geographic variations.

Quality assurance protocols, including peer review and editorial oversight, upheld the accuracy and relevance of all content. This methodological rigor underpins the reliability of the conclusions and recommendations presented throughout this report.

Bridging Insights to Innovation in Embolotherapy

The insights distilled here offer a roadmap for stakeholders seeking to harness the full potential of embolotherapy. By aligning innovation efforts with evolving clinical requirements and navigating tariff-induced headwinds, manufacturers can unlock new market segments and solidify their leadership. Regional nuances underscore the need for bespoke strategies that resonate with local regulatory environments and healthcare infrastructures.

Competitive differentiation will be driven by the ability to integrate advanced materials science, digital technologies, and clinical support services into cohesive solutions. Organizations that prioritize strategic partnerships and agile supply chains will be best positioned to adapt to shifting economic and policy landscapes. Ultimately, a patient-centric focus-underpinned by robust clinical evidence and seamless care pathways-will define long-term success in this dynamic market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Balloons
    • Coils
      • Bare Coils
      • Fibered Coils
    • Liquid Embolics
      • Ethylene Vinyl Alcohol Copolymer
      • N-Butyl Cyanoacrylate
    • Particle Embolics
      • Calibrated Microspheres
      • Polyvinyl Alcohol
    • Plugs
      • Vascular Plugs
      • Vena Cava Plugs
  • Application
    • Neurovascular Embolization
      • Arteriovenous Malformation
      • Cerebral Aneurysm
      • Tumor Embolization
    • Peripheral Embolization
      • Peripheral Arterial Embolization
      • Peripheral Venous Embolization
    • Prostate Artery Embolization
    • Transarterial Chemoembolization
    • Transarterial Radioembolization
    • Uterine Fibroid Embolization
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
      • Oncology Centers
      • Vascular Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Becton, Dickinson and Company
  • Penumbra, Inc.
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • MicroVention, Inc.
  • Asahi Intecc Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embolotherapy Market, by Product Type
8.1. Introduction
8.2. Balloons
8.3. Coils
8.3.1. Bare Coils
8.3.2. Fibered Coils
8.4. Liquid Embolics
8.4.1. Ethylene Vinyl Alcohol Copolymer
8.4.2. N-Butyl Cyanoacrylate
8.5. Particle Embolics
8.5.1. Calibrated Microspheres
8.5.2. Polyvinyl Alcohol
8.6. Plugs
8.6.1. Vascular Plugs
8.6.2. Vena Cava Plugs
9. Embolotherapy Market, by Application
9.1. Introduction
9.2. Neurovascular Embolization
9.2.1. Arteriovenous Malformation
9.2.2. Cerebral Aneurysm
9.2.3. Tumor Embolization
9.3. Peripheral Embolization
9.3.1. Peripheral Arterial Embolization
9.3.2. Peripheral Venous Embolization
9.4. Prostate Artery Embolization
9.5. Transarterial Chemoembolization
9.6. Transarterial Radioembolization
9.7. Uterine Fibroid Embolization
10. Embolotherapy Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
10.4.1. Oncology Centers
10.4.2. Vascular Centers
11. Americas Embolotherapy Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Embolotherapy Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Embolotherapy Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Boston Scientific Corporation
14.3.2. Terumo Corporation
14.3.3. Medtronic plc
14.3.4. Johnson & Johnson
14.3.5. Becton, Dickinson and Company
14.3.6. Penumbra, Inc.
14.3.7. Merit Medical Systems, Inc.
14.3.8. Cook Medical LLC
14.3.9. MicroVention, Inc.
14.3.10. Asahi Intecc Co., Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. EMBOLOTHERAPY MARKET MULTI-CURRENCY
FIGURE 2. EMBOLOTHERAPY MARKET MULTI-LANGUAGE
FIGURE 3. EMBOLOTHERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EMBOLOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BARE COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY FIBERED COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ETHYLENE VINYL ALCOHOL COPOLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY N-BUTYL CYANOACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CALIBRATED MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VENA CAVA PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 69. CANADA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 70. CANADA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 71. CANADA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 72. CANADA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 135. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 158. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 160. ITALY EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 161. ITALY EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 162. ITALY EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 163. ITALY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ITALY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. DENMARK EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 215. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. QATAR EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 230. QATAR EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 231. QATAR EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 232. QATAR EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 233. QATAR EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. QATAR EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 235. QATAR EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 236. QATAR EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. QATAR EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. FINLAND EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. FINLAND EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 245. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. EGYPT EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 271. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. EGYPT EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 275. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 276. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 278. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. TURKEY EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 281. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. TURKEY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 285. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 286. TURKEY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. TURKEY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 298. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. NORWAY EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 301. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. NORWAY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 305. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 306. NORWAY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. NORWAY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 308. POLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. POLAND EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 310. POLAND EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 311. POLAND EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 312. POLAND EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 313. POLAND EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. POLAND EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 315. POLAND EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 316. POLAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. POLAND EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 339. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. CHINA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 341. CHINA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 342. CHINA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 343. CHINA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 344. CHINA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. CHINA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 346. CHINA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 347. CHINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. CHINA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 349. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. INDIA EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 351. INDIA EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 352. INDIA EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, 2018-2030 (USD MILLION)
TABLE 353. INDIA EMBOLOTHERAPY MARKET SIZE, BY PLUGS, 2018-2030 (USD MILLION)
TABLE 354. INDIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. INDIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 356. INDIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 357. INDIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. INDIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 359. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 360. JAPAN EMBOLOTHERAPY MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 361. JAPAN EMBOLOTH

Companies Mentioned

The companies profiled in this Embolotherapy market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Becton, Dickinson and Company
  • Penumbra, Inc.
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • MicroVention, Inc.
  • Asahi Intecc Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.01 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Embolotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Type Coverage, Cancer Indication Coverage, Procedure Coverage, End User Coverage, Geographic Coverage and By Company) - Product Image

Embolotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Type Coverage, Cancer Indication Coverage, Procedure Coverage, End User Coverage, Geographic Coverage and By Company)

  • Report
  • 184 Pages
  • Global
From
Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 109 Pages
  • Global
From
Embolotherapy - Global Strategic Business Report - Product Image

Embolotherapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Embolotherapy Global Market Report 2025 - Product Image

Embolotherapy Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Embolotherapy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Embolotherapy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From

About the Embolotherapy Market

Embolotherapy is a minimally invasive medical procedure that involves the use of catheters to deliver therapeutic agents to a specific area of the body. The procedure is used to treat a variety of conditions, including vascular malformations, tumors, and arteriovenous malformations. Catheters are used to deliver embolic agents, such as coils, particles, and glue, to the target area. The catheters are inserted through a small incision in the skin and guided to the target area using imaging techniques such as X-ray, ultrasound, or computed tomography. The embolotherapy market is driven by the increasing prevalence of chronic diseases, the growing demand for minimally invasive procedures, and the availability of advanced catheter technologies. The market is further driven by the increasing adoption of embolotherapy in the treatment of various diseases, such as cancer, cardiovascular diseases, and neurological disorders. Some of the major companies in the embolotherapy market include Boston Scientific Corporation, Cook Medical, Medtronic, Terumo Corporation, Merit Medical Systems, Inc., and BTG plc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.